Which of the statements about the guideline for the screening and monitoring of interstitial lung disease among patients with systemic autoimmune rheumatic diseases are correct?
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
Myeloid deficiency of the mitochondrial transacetylase tafazzin upregulates mtROS, disrupting UPR and calcium homeostasis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback